Literature DB >> 20571257

Elevated plasma levels of antimicrobial polypeptides in patients with severe sepsis.

Ingrid Berkestedt1, Heiko Herwald, Lennart Ljunggren, Axel Nelson, Mikael Bodelsson.   

Abstract

We wanted to investigate if plasma levels of antimicrobial polypeptides (AMPs) are increased in severe sepsis and if they correlate with severity and mortality. Samples were collected from 31 sepsis patients at the intensive care unit. The Sequential Organ Failure Assessment (SOFA) score and 90-day mortality were registered, and inflammatory markers and AMP levels were measured by ELISA. A median SOFA score (13) and cardiovascular SOFA score (3) indicated multiorgan failure with severe circulatory derangement, and elevated cytokine levels indicated inflammatory activation. Levels of bactericidal/permeability-increasing protein, heparin-binding protein, alpha-defensins and lactoferrin but not LL-37 were elevated in sepsis patients compared with controls. Bactericidal/permeability-increasing protein levels correlated with mortality, with lower levels in survivors. Levels of all AMPs, except LL-37, positively correlated with the cardiovascular SOFA score. In conclusion, levels of several AMPs are increased in sepsis and correlate with circulatory derangement. This probably reflects neutrophil activation as part of an innate immune response. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571257     DOI: 10.1159/000317036

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  17 in total

1.  Increased plasma levels of heparin-binding protein in patients with shock: a prospective, cohort study.

Authors:  Michelle S Chew; Adam Linder; Stefan Santen; Anders Ersson; Heiko Herwald; Henrik Thorlacius
Journal:  Inflamm Res       Date:  2011-12-30       Impact factor: 4.575

2.  Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis.

Authors:  Joanna Koziel; Danuta Bryzek; Aneta Sroka; Katarzyna Maresz; Izabela Glowczyk; Ewa Bielecka; Tomasz Kantyka; Krzysztof Pyrć; Pavel Svoboda; Jan Pohl; Jan Potempa
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

3.  Cardiometabolic risk factors and lactoferrin: polymorphisms and plasma levels in French-Canadian children.

Authors:  Valérie Marcil; Sylvain Mayeur; Benoît Lamarche; Jade England; Mélanie Henderson; Edgard Delvin; Devendra Amre; Emile Levy
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

4.  The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation.

Authors:  Maryam F Salamah; Divyashree Ravishankar; Xenia Kodji; Leonardo A Moraes; Harry F Williams; Thomas M Vallance; Dina A Albadawi; Rajendran Vaiyapuri; Kim Watson; Jonathan M Gibbins; Susan D Brain; Mauro Perretti; Sakthivel Vaiyapuri
Journal:  Blood Adv       Date:  2018-11-13

5.  The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps.

Authors:  Kenji Daigo; Naotaka Yamaguchi; Takeshi Kawamura; Koichi Matsubara; Shuying Jiang; Riuko Ohashi; Yukio Sudou; Tatsuhiko Kodama; Makoto Naito; Kenji Inoue; Takao Hamakubo
Journal:  Mol Cell Proteomics       Date:  2012-01-25       Impact factor: 5.911

Review 6.  Antimicrobial peptides and their potential application in inflammation and sepsis.

Authors:  Tobias Schuerholz; Klaus Brandenburg; Gernot Marx
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

7.  The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis.

Authors:  Anna Gustafsson; Lennart Ljunggren; Mikael Bodelsson; Ingrid Berkestedt
Journal:  Biomark Insights       Date:  2012-04-10

8.  Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.

Authors:  Kenji Daigo; Takao Hamakubo
Journal:  Front Immunol       Date:  2012-12-13       Impact factor: 7.561

9.  Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care.

Authors:  Martin J Llewelyn; Mario Berger; Mark Gregory; Ravi Ramaiah; Amanda L Taylor; Ingo Curdt; Frédéric Lajaunias; Rolf Graf; Stuart J Blincko; Stephen Drage; Jonathan Cohen
Journal:  Crit Care       Date:  2013-03-26       Impact factor: 9.097

Review 10.  Antimicrobial Peptides in Human Sepsis.

Authors:  Lukas Martin; Anne van Meegern; Sabine Doemming; Tobias Schuerholz
Journal:  Front Immunol       Date:  2015-08-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.